Babcock International (BAB.L) — Company Research
Last Updated: 13 September 2026
Babcock International Group plc (LSE: BAB) is a FTSE 100 defence and nuclear engineering-services group. It does not primarily sell equipment; it maintains, refits, upgrades and operates other people's equipment and infrastructure, from nuclear submarines at Devonport and HMNB Clyde to military flying training in France and the UK. Defence and nuclear together account for roughly 80% of revenue. FY2026, the year to 31 March 2026 reported on 22 June 2026, produced statutory revenue of £5,177.7m, up 8% organically, and underlying operating profit of £293.3m — a figure held down by a £140.0m charge on the Type 31 frigate programme. Excluding that charge, underlying operating profit was £433.3m, up 19%, at an 8.2% margin that beat the company's own 8.0% target. Underlying free cash flow rose 71% to £261.8m, net debt fell to £329.0m, and the dividend was raised 15% to 7.5p. The market has been unimpressed: at 965.4p on 11 September 2026 the shares sit roughly 37% below their 52-week high of 1,527p set in January. This report sets out the reported figures, the programme pipeline, and what the numbers currently imply — without analyst opinions or price targets.
1. Company Snapshot
| Field | Value |
|---|---|
| Ticker / exchange | BAB.L — London Stock Exchange, FTSE 100 constituent since March 2025 (ISIN GB0009697037) |
| Sector | Aerospace & Defence, specifically defence and nuclear engineering services |
| Headquarters | London, United Kingdom |
| CEO / Leadership | Harry Holt (Chief Executive since 31 July 2026, previously CEO of the Nuclear sector and Deputy CEO from 1 April 2026); David Mellors (Chief Financial Officer). David Lockwood OBE, CEO from September 2020, stepped down on 31 July 2026 and remains with the company until retirement at the end of January 2027 |
| Employees | Approximately 29,000, split roughly Nuclear 11,100, Marine 7,500, Land 6,000 and Aviation 2,600. FY2026 intake included 500 apprentices and more than 260 graduates, the largest UK intake to date |
| Revenue (FY2026, statutory) | £5,177.7m for the year ended 31 March 2026, up 7.2% as reported and 8% organically at constant currency. Excluding the Type 31 revenue reversal of £95.5m, revenue was £5,273.2m |
| Underlying operating profit (FY2026) | £293.3m at a 5.7% margin; £433.3m at an 8.2% margin excluding the £140.0m Type 31 charge, against a company target of 8.0% |
| Net income (FY2026) | £211.2m attributable to owners of the parent; basic statutory EPS 42.1p, underlying EPS 39.6p |
| Share price | 965.4p (close, 11 September 2026) |
| Market cap | Approximately £4.74bn, on 490,592,437 shares in issue excluding treasury at 10 September 2026 |
| Contract backlog | £9.8bn at 31 March 2026, down from £10.4bn a year earlier, excluding roughly £2.8bn of framework orders. Approximately 70% of FY2027 revenue was already under contract at 1 April 2026 |
| Dividend | 7.5p for FY2026, up 15%, comprising a 2.5p interim and a 5.0p final payable 25 September 2026 |
| Fiscal year end | 31 March |
2. The Bull and Bear Case
Bull Case
- Nuclear is doing the heavy lifting: the Nuclear sector generated £2,070.4m of FY2026 revenue, 40.0% of the Group, with underlying operating profit up 23% to £197.1m at a 9.5% margin and 14% revenue growth at constant currency. It is already operating above the Group's medium-term margin target.
- The margin target was beaten on the underlying business: excluding the Type 31 charge, the FY2026 underlying operating margin was 8.2% against a stated 8.0% target, up 70 basis points, with underlying operating profit up 19% to £433.3m. The medium-term target of at least 9% therefore requires continuation rather than transformation.
- The balance sheet has been rebuilt: net debt excluding leases was just £22.7m at 31 March 2026 on covenant-basis leverage of 0.2x against a 3.5x covenant maximum, with £739.9m of cash and roughly £1.4bn of total facilities. Underlying free cash flow rose 71% to £261.8m, funding a 15% dividend increase and two consecutive £200m buybacks.
- Revenue visibility is unusually high for the valuation: approximately 70% of FY2027 revenue was already contracted at 1 April 2026, on top of a £9.8bn backlog and £2.8bn of framework orders excluded from it. The company describes UK civil nuclear alone as a £25–30bn addressable opportunity to 2050.
Bear Case
- Type 31 has now been written down twice: the £140.0m FY2026 charge, covering the entire remaining cost to complete after higher-than-expected rework on ship one, follows a £90m charge on the same programme disclosed in FY2024. Two write-downs on one fixed-price contract in three years is a pattern, not an accident.
- The largest support contract is running on a bridge: the £3.5bn Future Maritime Support Programme expired on 31 March 2026 and has been operating under a six-month bridging agreement since 1 April 2026. The replacement, known as Gateway, was only at Letter of Intent stage with a target of finalisation by October 2026 — weeks away.
- Backlog is shrinking: contract backlog fell from £10.4bn to £9.8bn over FY2026, with Marine down £220m, Nuclear down £191m and Land down £379m. Only Aviation grew. Revenue cover is being consumed faster than it is being replaced.
- Single-customer concentration is structural, not cyclical: defence and nuclear are roughly 80% of Group revenue and Nuclear alone is 86% UK defence. Babcock's own principal risk disclosure describes markets "characterised by a relatively small number of major customers, which are owned or controlled by local or national governments". Management has explicitly flagged the delayed publication of the UK Defence Investment Plan as a source of uncertainty.
- International wins remain frameworks rather than firm orders: Babcock was not selected for Sweden's Luleå Class programme in late May 2026, and the Indonesia Maritime Partnership Programme, Denmark, Poland and the Canadian Patrol Submarine Project all remain frameworks, memoranda or teaming agreements. The export thesis is not yet in the order book.
3. Revenue Segments
Babcock reports through four sectors. The percentages below are of FY2026 statutory revenue of £5,177.7m for the year ended 31 March 2026.
| Segment | % of revenue | What it is |
|---|---|---|
| Nuclear | 40.0% (£2,070.4m) | Submarine deep maintenance and refits at Devonport, base operations at HMNB Clyde, submarine defuelling and dismantling, AWE plant work, and civil nuclear at Hinkley Point C and Sizewell C. Underlying operating profit £197.1m, up 23%, at a 9.5% margin; 86% UK defence, 14% UK civil; approximately 11,100 employees |
| Marine | 30.7% (£1,591.5m) | Type 31 frigate construction at Rosyth, Royal Navy surface fleet support, missile compartments for the Columbia and Dreadnought programmes, Skynet satellite operations and LGE cryogenic systems. Reported an underlying operating loss of £29.8m after the £140.0m Type 31 charge; excluding it, profit of £110.2m, up 14%, at a 6.5% margin. Revenue split 48% UK defence, 29% international defence, 23% civil |
| Land | 20.9% (£1,084.4m) | British Army vehicle support under the £1bn DSG contract, Jackal 3 and light utility vehicle production, mission systems, and civil businesses in rail and South Africa. Underlying operating profit £95.3m, up 11%, at an 8.8% margin. Revenue fell 3% at constant currency as civil businesses shrank |
| Aviation | 8.3% (£431.4m) | Military flying training including the 17-year French Mentor 2 contract and the RAF Light Aircraft Flying Task, emergency services aviation in Canada and Australia, and Ukrainian pilot training. Underlying operating profit £30.7m, up 54%, at a 7.1% margin; the fastest-growing sector at 34% constant-currency revenue growth |
4. Business Model & Moat
How it makes money. Babcock earns fees for keeping complex, safety-critical assets available and serviceable over multi-decade contracts, rather than for selling hardware. Most revenue arrives through long-term support agreements with the UK Ministry of Defence and government-owned nuclear bodies, with pricing set as a mix of cost-plus, target-cost and firm-price arrangements. The consequence is visible in the numbers: approximately 70% of FY2027 revenue was already contracted at 1 April 2026, and the £9.8bn backlog represents close to two years of revenue before any new award.
Why the position is defensible. The moat is licence, infrastructure and clearance rather than intellectual property. Babcock is the sole provider of deep maintenance for UK nuclear submarines at Devonport, operates HMNB Clyde, and is one of only two UK naval shipbuilders. Replicating that requires nuclear-licensed docks, a security-cleared workforce and decades of regulatory history — which is why the reopening of 15 Dock at Devonport, restoring twin-stream submarine maintenance, is a strategic event rather than a maintenance milestone.
Where the model breaks. The same contract structure that provides visibility transfers execution risk onto Babcock wherever pricing is firm. The Type 31 programme is the clearest illustration: a fixed-price frigate build that absorbed a £90m charge in FY2024 and a further £140.0m in FY2026, the latter covering the entire remaining cost to complete after rework during the outfitting of ship one. Services revenue carries steadier margins; new-build construction is where the accounting surprises originate.
What it does with the cash. Underlying free cash flow of £261.8m in FY2026, up 71%, funded £34.7m of dividends and £155.3m of share buybacks, with net debt including leases cut to £329.0m. Management's medium-term framework is mid-single-digit organic revenue growth, an underlying operating margin of at least 9%, and average underlying operating cash conversion of at least 80% — FY2026 delivered 84% excluding the Type 31 charge. Price action against these fundamentals can be followed on the ChartsView Live Charts page.
5. Financial Health
All figures are taken from Babcock's audited results statements and Annual Reports. Babcock's fiscal year ends 31 March, so FY2026 is the year ended 31 March 2026. Statutory and underlying revenue are identical in every year shown; Babcock's adjusting items affect profit, not the revenue line.
| Fiscal Year | Revenue (£m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY2022 | £4,101.8m | +3.3% | 32.5p | 30.7p | Nil | £847.7m |
| FY2023 | £4,438.6m | +8.2% | (6.9)p | 17.7p | Nil | £768.4m |
| FY2024 | £4,390.1m | −1.1% | 32.9p | 30.8p | 5.0p | £747.1m |
| FY2025 | £4,831.3m | +10.0% | 49.1p | 50.3p | 6.5p | £750.7m |
| FY2026 | £5,177.7m | +7.2% | 42.1p | 39.6p | 7.5p | £474.9m |
Adjusted EPS is Babcock's "underlying basic earnings per share", which excludes amortisation of acquired intangibles, acquisition and divestment items and fair-value movements on derivatives. The FY2026 figure of 39.6p becomes 60.5p excluding the £140.0m Type 31 charge. The FY2023 statutory loss of 6.9p per share reflects impairments and disposal losses in that year. Dividends were suspended through FY2021 to FY2023 and reinstated in FY2024. Long-term debt is the non-current bank and other borrowings line and excludes lease liabilities, which were a further £254.2m non-current at 31 March 2026; the FY2026 fall reflects the £300m bond maturing 5 October 2026 reclassifying into current borrowings rather than repayment.
| Quarter / Half | Revenue | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| H1 FY2026 (to 30 Sep 2025) | £2,538.6m | 28.5p | 33.7p |
| H2 FY2026 (derived, to 31 Mar 2026) † | £2,639.1m | 11.1p | 8.4p |
| H1 FY2025 (to 30 Sep 2024) | £2,408.9m | 23.5p | 25.7p |
| FY2026 (full year to 31 Mar 2026) | £5,177.7m | 39.6p | 42.1p |
† Babcock reports half-yearly and does not publish quarterly accounts. The H2 FY2026 line is derived by subtracting reported H1 FY2026 figures from reported FY2026 totals; it is not a separately published statement. The weak derived second half is almost entirely the £140.0m Type 31 charge, which was announced on 13 May 2026 and booked at the year end. Note also that the interim statutory EPS exceeded underlying EPS in H1 FY2026 because fair-value derivative movements were a credit in that period.
Balance sheet and cash flow at 31 March 2026, from the FY2026 results statement. Non-current bank and other borrowings were £474.9m and current borrowings £316.0m, with total lease liabilities of £307.3m, against cash and cash equivalents of £739.9m. Company-reported net debt was £329.0m including leases and £22.7m excluding them, on covenant-basis leverage of 0.2x against a 3.5x covenant. Total equity was £629.3m. In FY2026, net cash flows from operating activities were £402.4m, purchases of property, plant and equipment and intangibles totalled £160.3m, and depreciation, amortisation and impairment added back in the cash flow statement totalled £145.6m — comprising £67.5m on property, plant and equipment, £50.4m on right-of-use assets and £27.7m on intangibles. The covenant calculation uses a narrower £85.2m. The net retirement benefit position was a £34.0m deficit, worse than the £8.4m deficit a year earlier, with roughly £25m a year of deficit contributions modelled.
6. Valuation Metrics
Raw metrics, September 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Share price | 965.4p (close, 11 September 2026), down 30.0% over six months and 16.6% over twelve |
| Market cap | Approximately £4.74bn (490,592,437 shares in issue excluding 15,004,160 treasury shares at 10 September 2026 × 965.4p) |
| Enterprise value | Approximately £4.79bn (market cap £4.74bn + total borrowings £790.9m − cash and short-term investments £741.2m, all per the 31 March 2026 balance sheet; borrowings are non-current £474.9m plus current £316.0m and exclude £307.3m of lease liabilities) |
| Trailing P/E (GAAP) | Approximately 22.9x (965.4p ÷ FY2026 basic statutory EPS of 42.1p, which is also the trailing twelve-month figure as no period after 31 March 2026 has been reported). On underlying EPS of 39.6p it is 24.4x; on underlying EPS excluding the £140.0m Type 31 charge of 60.5p it is 16.0x |
| P/E (forward) | Not published reliably. Three data providers surveyed in July 2026 gave 15.9x, 16.4x and 26.2x — too wide a spread to quote as a single figure, and Babcock issues percentage-based guidance rather than an EPS number. The nearest defensible anchor is the 16.0x implied by FY2026 underlying EPS excluding the Type 31 charge |
| P/S (TTM) | Approximately 0.91x (market cap £4.74bn ÷ FY2026 statutory revenue of £5,177.7m) |
| EV/EBITDA (TTM) | Approximately 10.6x (EV £4.79bn ÷ EBITDA £450.7m; EBITDA is FY2026 statutory operating profit of £305.1m plus £145.6m of depreciation, amortisation and impairment). The wider £145.6m cash-flow add-back is used rather than the narrower £85.2m covenant measure. Note this EBITDA is depressed by the £140.0m Type 31 charge; adding it back gives EBITDA of about £590.7m and a multiple of roughly 8.1x |
| P/FCF | Approximately 19.6x (market cap £4.74bn ÷ FCF £242.1m; FCF = FY2026 operating cash flow £402.4m − capital expenditure £160.3m per the FY2026 cash flow statement). On the company's own reported underlying free cash flow of £261.8m it is approximately 18.1x |
| 52-week high | 1,527.0p, set on 14 January 2026 |
| 52-week low | 902.4p, set on 29 June 2026 |
| Dividend yield (trailing) | Approximately 0.78% on the 7.5p declared for FY2026 |
| Short interest (% of float) | 2.11% of issued share capital, position date 9 September 2026, per the Financial Conduct Authority's aggregated net short positions file. The trend has hovered between 1.80% and 2.73% since July 2026. Do not use US aggregator figures for this line — those describe the OTC depositary receipt, not the London ordinary shares |
| Days to cover | Not derivable for the London line: the FCA's aggregated disclosure publishes a percentage only, with no share count or volume data, and individual holder disclosure for Babcock has ceased. Verify at fca.org.uk short-selling disclosures against daily LSE turnover |
The single most important judgement in this table is whether to value Babcock on reported FY2026 earnings or on earnings excluding the Type 31 charge. The gap is wide — 22.9x against 16.0x — and the charge was stated to cover the entire remaining cost to complete on that programme, meaning it should not recur on Type 31. It is also the second such charge on the same contract in three years. Both figures are shown so the reader can decide. Scheduled macro releases that may move UK defence names are listed on the ChartsView Economic Calendar.
7. What Are They Building
Naval shipbuilding and exports. Five Type 31 Inspiration Class frigates are in build at Rosyth, with ships one and two floated off, the keel laid for ship three and steel cut for ship four. The programme is typically under 4% of Group revenue but has absorbed £230m of charges across FY2024 and FY2026. The export derivative, Arrowhead 140, underpins the up-to-£4bn Indonesia Maritime Partnership Programme framework signed in November 2025 plus a Letter of Intent for two further licences, a strategic cooperation agreement with Poland's PGZ, and an ongoing Danish evaluation. The smaller Arrowhead 120 was not selected for Sweden's Luleå Class in late May 2026.
Submarines and the deterrent. Rosyth delivered a record 12 missile tube assemblies in FY2026 for the US Columbia Class and UK Dreadnought programmes, and has been designated by the Ministry of Defence to host a Contingent Dock Facility for Dreadnought from the early 2030s. At Devonport, 15 Dock reopened to restore twin-stream submarine maintenance, 9 Dock is complete with HMS Victorious docked down for deep maintenance, and the Submarine Refit Complex is progressing. A three-year £114m programme awarded in June 2025 covers the defuelling of four submarines, the first Trafalgar Class defuel in over two decades, while dismantling of Swiftsure was 40% complete at March 2026 with 90% of material reused or recycled.
AUKUS and international nuclear. H&B Defence, the joint venture with HII, won its first contract under Australia's Submarine Supplier Qualification pilot, and Babcock specialists have deployed to Australia for Astute Class maintenance ahead of Submarine Rotational Force–West from 2027. An expanded HII partnership brought an initial engineering contract on the US Virginia Class, with Rosyth now authorised to manufacture complex submarine assemblies. In Canada, Babcock has a teaming agreement with Hanwha Ocean for the Canadian Patrol Submarine Project.
Civil nuclear. Cavendish headcount on the Hinkley Point C mechanical, electrical and HVAC alliance has grown from roughly 550 to 900. Sizewell C is now fully funded under a Regulated Asset Base model with Babcock in the alliance. Through Litmus Nuclear, a joint venture with Amentum, Babcock is Owner's Engineer to Great British Energy–Nuclear's small modular reactor programme on a 14-year contract worth up to roughly £300m, with the first unit at Wylfa. The company frames UK civil nuclear as a £25–30bn addressable opportunity to 2050.
Land and aviation. The £1bn five-year DSG strategic support partnership with the British Army has mobilised and ramped up; Jackal 3 deliveries complete in FY2027; 270 light utility vehicles developed with Toyota are being delivered, with a first tranche exported to Albania; and a teaming agreement with Patria targets a 6x6 armoured personnel carrier for the UK. In Aviation, the 17-year French Mentor 2 military flying training contract is the single largest growth driver, alongside a four-year RAF Light Aircraft Flying Task extension, a £70m UK military flying training infrastructure contract, fast-jet lead-in training for Ukrainian F-16 pilots, and an eight-year A$230m Australian Border Force helicopter contract.
8. Competitive Landscape
Babcock's competitive set differs by sector: BAE Systems in naval shipbuilding and submarine work, QinetiQ and Serco in government technical services, and Thales and Fincantieri internationally. No published 2026 market-share dataset exists for UK naval sustainment, so the table compares scale and one verifiable operating metric each. Market capitalisations were re-checked on 11 September 2026.
| Peer | Market cap (September 2026) | Key 2025 metric |
|---|---|---|
| Rolls-Royce Holdings (RR.L) | £118.8bn per the London Stock Exchange, at 1,454.60p | Supplies the nuclear reactors for the submarines Babcock maintains and is a partner rather than a direct rival; carries 25 times Babcock's market value and has been the reference point for how far a UK defence-adjacent industrial can re-rate |
| BAE Systems (BA.L) | £57.7bn per the London Stock Exchange, at 1,898.00p | The UK's other naval shipbuilder and Babcock's closest structural comparator. BAE's Maritime segment generated £6,579m of FY2025 revenue at a 6.6% return, against Babcock's whole-group £5,177.7m at an underlying 8.2% excluding the Type 31 charge |
| Thales (HO.PA) | €46.7bn, at €226.80 | Competes internationally in naval systems, training and simulation, and secure communications, and is a supplier into several of the platforms Babcock supports |
| Fincantieri (FCT.MI) | €4.5bn, at €12.45 | The closest continental comparator by size and business mix — a naval shipbuilder competing for the same export frigate and submarine-support opportunities Babcock is chasing in Indonesia, Denmark and Poland |
| QinetiQ Group (QQ.L) | £2.41bn per the London Stock Exchange, at 472.40p | Guides to 3–5% revenue growth, 8–10% EPS growth and above 90% cash conversion for FY2027, against Babcock's mid-single-digit growth, at-least-9% margin and at-least-80% cash conversion targets — a direct read on relative UK defence-services quality |
| Serco Group (SRP.L) | £2.41bn per the London Stock Exchange, at 248.20p | Competes for UK and international government outsourced services contracts, including defence support, though with far less nuclear and shipbuilding exposure |
At a £4.74bn market capitalisation Babcock now sits near the bottom of the FTSE 100, having rejoined the index in March 2025. It was not in the September 2026 FTSE quarterly review change list, so it remains a constituent for now. UK defence names can be discussed on the ChartsView Forum.
9. Leadership & Insider Activity
Harry Holt became Chief Executive and a director with effect from 31 July 2026, having been Deputy CEO from 1 April 2026 and, before that, CEO of the Nuclear sector — the business that grew revenue 54% between FY2023 and FY2025 at roughly 9% margins. His appointment was announced on 23 January 2026 alongside the retirement of David Lockwood OBE, CEO since September 2020, who stepped down as a director on 31 July 2026 and remains with the company until the end of January 2027. David Mellors continues as Chief Financial Officer. Sector leadership comprises Nicholas Hine as Chief Growth Officer and CEO Marine, Neal Misell at Nuclear, Louise Atkinson at Land and Mission Systems, and Pierre Basquin at Aviation.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| Rosemary Parratt (PCA of Jack Borrett) | 03 Sep 2026 | Sell | 24,329 | £10.06 | Approximately £244,750 | Person closely associated, open market |
| David Mellors (CFO) | 03 Aug 2026 | Vest of 52,623, then sell | 24,804 sold, 27,819 retained | £11.443276 | £283,839.02 | PSP vest, sale to cover tax |
| Neal Misell (CEO Nuclear) | 03 Aug 2026 | Vest of 74,126, then sell | 34,936 sold, 39,190 retained | £11.443276 | £399,782.29 | PSP vest, sale to cover tax |
| Louise Atkinson (CEO Land & Mission Systems) | 05 Aug 2026 | Vest of 33,943, then full sale | 33,943 | £11.965 | £406,128.00 | PSP vest, full disposal |
| Harry Holt (then Deputy CEO) | 07 Jul 2026 | Award, no cash consideration | 214,728 PSP plus 14,255 DSBP | Nil cost | Nil cost | Performance Share Plan and Deferred Share Bonus Plan |
| Nicholas Hine (Chief Growth Officer, CEO Marine) | 07 Jul 2026 | Award, no cash consideration | 133,609 PSP plus 9,868 DSBP | Nil cost | Nil cost | Performance Share Plan and Deferred Share Bonus Plan |
| David Mellors (CFO) | 16 Jan 2026 | Buy | 69, 67 and 254 across three days | 1,458p to 1,489p | De minimis | Dividend reinvestment plan |
Read carefully, 2026 shows no discretionary open-market purchases by directors beyond small dividend reinvestments. Every disposal is a mechanical vesting transaction, mostly to cover tax, and several executives retained roughly half the vested shares. Worth noting for context: the August sales were executed at about £11.44, roughly 18% above the 11 September price of 965.4p. The company itself has been a consistent buyer, completing a first £200m buyback in April 2026 and repurchasing 3,187,233 shares for £33,197,441 between 1 July and 10 September 2026 under a second £200m programme. BlackRock disclosed a threshold crossing on 9 September 2026.
10. Key Risks
- Fixed-price contract execution (Operational): the £140.0m Type 31 charge in FY2026 followed a £90m charge on the same programme in FY2024. Babcock states the latest charge covers the entire remaining cost to complete, but two write-downs on one contract in three years establishes that firm-price new-build work is where estimation error concentrates.
- FMSP and Gateway re-let (Contractual): the £3.5bn Future Maritime Support Programme, Babcock's largest support contract, expired on 31 March 2026 and has run on a six-month bridging agreement since. The multi-year replacement was only at Letter of Intent stage with an October 2026 target, so the bridge expires within weeks of this report.
- Single-customer concentration (Structural): defence and nuclear are roughly 80% of Group revenue, and the Nuclear sector alone, at 40% of the Group, is 86% UK defence. Babcock's own principal risk disclosure acknowledges reliance on a small number of government-owned or government-controlled customers.
- Defence budget timing and political slippage (Macro): management explicitly cited the delayed publication of the UK Defence Investment Plan as evidence that governments are balancing defence priorities against fiscal constraints. The share price fell roughly 40% from its January 2026 high to its June 2026 low against that backdrop.
- Backlog decline (Commercial): contract backlog fell from £10.4bn to £9.8bn over FY2026, with Marine, Nuclear and Land all down and only Aviation growing. Order replacement is currently running behind order consumption.
- Near-term refinancing (Financial): £316.0m of borrowings sit in current liabilities because of the £300m bond maturing 5 October 2026, with a €550m bond hedged at £493m following on 13 September 2027. This is well covered by £739.9m of cash and roughly £1.4bn of facilities, but it is a live refinancing calendar rather than a theoretical one.
- Specialist skills availability (Operational): Babcock's own principal risk disclosure notes that many required competencies are "deeply specialist and in scarce supply" in its operating territories. That constraint is being tested simultaneously by ramp-ups at Hinkley Point C, Devonport, Rosyth and the French Mentor 2 mobilisation.
- Pension deficit drift (Financial): the net retirement benefit position deteriorated to a £34.0m deficit at 31 March 2026 from £8.4m a year earlier, with roughly £25m a year of deficit contributions in excess of the income statement charge modelled in the going-concern base case.
11. Recent Developments
The twelve months to September 2026 combined a leadership handover, a large contract charge and a sharp de-rating with materially improved underlying profitability. Items are listed most recent first.
- 11 Sep 2026 — Buyback progress and a BlackRock threshold crossing. Babcock reported repurchasing 125,074 shares on 10 September at a volume-weighted average of £9.7010, bringing the second £200m programme to 3,187,233 shares for £33,197,441 since 1 July 2026. BlackRock separately disclosed a holdings threshold crossing dated 9 September 2026.
- 03 Jul 2026 — Harry Holt confirmed as CEO. The board confirmed Holt as director and Chief Executive with effect from 31 July 2026, with David Lockwood stepping down as director and CEO the same day while remaining with the company until retirement at the end of January 2027.
- 29 Jun 2026 — Shares touch a 52-week low. The stock hit 902.4p, down from 1,527.0p on 14 January 2026, a fall of roughly 40% from high to low across five months. The Annual Report and Financial Statements 2026 were published the same day.
- 22 Jun 2026 — FY2026 results. Revenue of £5,177.7m, up 8% organically; statutory operating profit £305.1m; underlying operating profit £293.3m, or £433.3m and up 19% excluding the Type 31 charge, at an 8.2% margin against an 8.0% target; underlying free cash flow up 71% to £261.8m; net debt down to £329.0m; backlog £9.8bn; full-year dividend up 15% to 7.5p. The statement also disclosed that Arrowhead 120 had not been selected for Sweden's Luleå Class programme in late May 2026.
- 13 May 2026 — Type 31 charge of £140m flagged, second buyback announced. The post-close trading update disclosed a £140m charge on the Type 31 programme including roughly £100m of revenue reversal, driven by higher-than-expected rework during the outfitting of ship one, and simultaneously announced a new £200m share buyback.
- 01 Apr 2026 — FMSP bridging agreement signed. Following expiry of the five-year £3.5bn Future Maritime Support Programme on 31 March 2026, Babcock agreed a six-month bridge with the Ministry of Defence, which issued a Letter of Intent to finalise the multi-year replacement contract by October 2026.
- 23 Jan 2026 — Q3 trading update and CEO succession. Babcock confirmed the 8% FY2026 margin target, announced selection as prime industrial partner for Indonesia's up-to-£4bn Maritime Partnership Programme with agreement for two further Arrowhead 140 licences, and disclosed an expanded HII partnership extending to the US Virginia Class programme. Separately the board announced David Lockwood's retirement and named Harry Holt as successor.
- 21 Nov 2025 — H1 FY2026 results. Revenue of £2,538.6m, underlying operating profit up 19% to £201.1m, underlying margin up 90 basis points to 7.9%, underlying EPS up 21% to 28.5p, and the interim dividend raised 25% to 2.5p.
- 04 Sep 2025 — Marine investor event at Rosyth. Babcock hosted investors at the Type 31 build facility to set out advanced manufacturing capability and the Arrowhead 140 export strategy.
12. Key Dates to Watch
- 16 Sep 2026 — Annual General Meeting and trading update at 10:30am, the first commentary on trading since 1 April 2026 and the vote on the 5.0p final dividend
- 25 Sep 2026 — payment date for the FY2026 final dividend of 5.0p; the ex-dividend date of 13 August 2026 has already passed
- 05 Oct 2026 — £300m bond matures, the near-term refinancing event sitting behind the £316.0m of current borrowings
- Expected Oct 2026 — target date for finalising the Gateway replacement for the Future Maritime Support Programme, per the Ministry of Defence Letter of Intent
- Expected Nov 2026 — H1 FY2027 half-year results for the six months to 30 September 2026, based on the 21 November 2025 and 13 November 2024 precedents. No date has been published
- Expected Jan 2027 — Q3 FY2027 trading update, based on the 23 January 2026 precedent, and the formal retirement of David Lockwood from the company
- 31 Mar 2027 — expected completion of the second £200m share buyback programme, and the FY2027 fiscal year end
- Expected Jun 2027 — FY2027 full-year results, based on the 22 June 2026 and 25 June 2025 precedents
- 13 Sep 2027 — €550m bond matures, hedged at £493m
Babcock's published financial calendar currently lists only the September 2026 AGM, so every date beyond that is derived from prior-year reporting patterns and is marked as expected rather than confirmed. The nearest catalyst by some distance is the AGM trading update, which falls three days after the date of this report.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. Babcock International maintains, refits and operates other organisations' safety-critical defence and nuclear assets under multi-decade contracts rather than selling hardware, with defence and nuclear together roughly 80% of revenue and a near-monopoly on UK nuclear submarine deep maintenance at Devonport. FY2026, the year to 31 March 2026 reported on 22 June 2026, produced statutory revenue of £5,177.7m, up 8% organically, and underlying operating profit of £293.3m — or £433.3m and up 19% at an 8.2% margin excluding a £140.0m Type 31 frigate charge, beating the company's own 8.0% target. Underlying free cash flow rose 71% to £261.8m, net debt fell to £329.0m, and the dividend rose 15% to 7.5p alongside a second £200m buyback. Management guides medium-term to mid-single-digit organic growth, an underlying margin of at least 9% and cash conversion of at least 80%, with approximately 70% of FY2027 revenue already contracted at 1 April 2026 and Nuclear, at 40% of the Group, already earning a 9.5% margin.
What would confirm or break it. Confirmation would be the 16 September 2026 AGM trading update and the November half-year showing the ex-Type 31 margin trajectory holding toward 9%, the Gateway replacement for the £3.5bn Future Maritime Support Programme signed by its October 2026 target, and backlog stabilising after falling from £10.4bn to £9.8bn. The thesis breaks if fixed-price execution produces a third charge on Type 31 or a first on another new-build programme, if the Gateway re-let slips or lands on materially worse terms given the six-month bridge expires within weeks, or if UK Ministry of Defence budget timing — management has already flagged the delayed Defence Investment Plan — keeps converting a growing addressable market into frameworks and letters of intent rather than firm orders, as happened with Sweden's Luleå Class in May 2026.
Watchpoints
- ConfirmsAGM and trading update (3 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Nuclear is doing the heavy lifting:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "FMSP and Gateway re-let (Contractual):" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 13 Sep 2026.
